Maureen Passaro

1.0k total citations
16 papers, 555 citations indexed

About

Maureen Passaro is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Genetics. According to data from OpenAlex, Maureen Passaro has authored 16 papers receiving a total of 555 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Reproductive Medicine, 5 papers in Obstetrics and Gynecology and 3 papers in Genetics. Recurrent topics in Maureen Passaro's work include Endometriosis Research and Treatment (4 papers), Ovarian cancer diagnosis and treatment (3 papers) and Uterine Myomas and Treatments (3 papers). Maureen Passaro is often cited by papers focused on Endometriosis Research and Treatment (4 papers), Ovarian cancer diagnosis and treatment (3 papers) and Uterine Myomas and Treatments (3 papers). Maureen Passaro collaborates with scholars based in Italy, United States and Hungary. Maureen Passaro's co-authors include Robert E. Ratner, Claresa Levetan, Mary E. Kass, Kathleen Jablonski, Lynnette K. Nieman, K. A. Jablonski, Diana Blithe, Pamela Stratton, Richard P. Blye and Frank S. Czerwiec and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and International Journal of Obesity.

In The Last Decade

Maureen Passaro

15 papers receiving 516 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maureen Passaro Italy 7 350 132 86 85 72 16 555
Paola Galoppi Italy 11 85 0.2× 92 0.7× 43 0.5× 40 0.5× 65 0.9× 42 349
Rossana Román Chile 12 313 0.9× 163 1.2× 14 0.2× 50 0.6× 76 1.1× 38 491
Lars‐Åke Mattsson Sweden 8 298 0.9× 179 1.4× 22 0.3× 84 1.0× 54 0.8× 8 398
Milagros Alonso Spain 12 179 0.5× 83 0.6× 19 0.2× 97 1.1× 131 1.8× 23 473
Mithat Erenus Türkiye 17 226 0.6× 146 1.1× 36 0.4× 304 3.6× 242 3.4× 48 700
Purvis L. Martin United States 11 241 0.7× 248 1.9× 80 0.9× 83 1.0× 44 0.6× 23 580
Lía Nattero‐Chávez Spain 12 175 0.5× 64 0.5× 27 0.3× 109 1.3× 74 1.0× 41 394
Kresten Rubeck Petersen Denmark 13 128 0.4× 53 0.4× 27 0.3× 88 1.0× 176 2.4× 21 391
O. Hars Germany 17 77 0.2× 85 0.6× 100 1.2× 20 0.2× 103 1.4× 33 688
Drahomíra Springer Czechia 12 290 0.8× 20 0.2× 116 1.3× 33 0.4× 56 0.8× 37 603

Countries citing papers authored by Maureen Passaro

Since Specialization
Citations

This map shows the geographic impact of Maureen Passaro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maureen Passaro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maureen Passaro more than expected).

Fields of papers citing papers by Maureen Passaro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maureen Passaro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maureen Passaro. The network helps show where Maureen Passaro may publish in the future.

Co-authorship network of co-authors of Maureen Passaro

This figure shows the co-authorship network connecting the top 25 collaborators of Maureen Passaro. A scholar is included among the top collaborators of Maureen Passaro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maureen Passaro. Maureen Passaro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Passaro, Maureen, et al.. (2017). Phytoestrogens for menopausal vasomotor symptoms: efficacy of soybean isoflavones supplements for alleviating menopausal symptoms is positively related to hot flushes frequency. Clinical and Experimental Obstetrics & Gynecology. 44(4). 521–523. 1 indexed citations
2.
Iafusco, Dario, Paola Pirillo, Edoardo Tartaglia, et al.. (2012). M222 BREAKING DOWN MISCLASSIFICATIONS: NOT ALL GESTATIONAL DIABETES NEED TREATMENT AS NOT ALL CHILDREN NEED INSULIN. International Journal of Gynecology & Obstetrics. 119(S3).
3.
Monteverde, A, et al.. (2006). Vascular endothelial growth factor (VEGF): can we use it as prognostic factor in endometrial cancer?. PubMed. 58(5). 411–5. 3 indexed citations
4.
Monteverde, A, et al.. (2006). Double laparotomy wound recurrence of endometrial carcinoma.. PubMed. 27(3). 307–9. 4 indexed citations
5.
Monteverde, A, et al.. (2006). Female adnexal tumor of probable wolffian origin: clinicopathological, immunohistochemical and cytofluorimetric analyses of a 22-year-old virgin. case report.. PubMed. 27(3). 313–6. 4 indexed citations
6.
Passaro, Maureen, et al.. (2005). Comparative evaluation of standard criteria and CA-125 in ovarian cancers treated with platinum or paclitaxel.. PubMed. 26(3). 285–7. 6 indexed citations
7.
Howard, Barbara V., Lucile L. Adams‐Campbell, Catherine Allen, et al.. (2004). Insulin resistance and weight gain in postmenopausal women of diverse ethnic groups. International Journal of Obesity. 28(8). 1039–1047. 31 indexed citations
8.
Blithe, Diana, Lynnette K. Nieman, Richard P. Blye, Pamela Stratton, & Maureen Passaro. (2003). Development of the selective progesterone receptor modulator CDB-2914 for clinical indications. Steroids. 68(10-13). 1013–1017. 74 indexed citations
9.
Passaro, Maureen. (2003). Luteal phase dose-response relationships of the antiprogestin CDB-2914 in normally cycling women. Human Reproduction. 18(9). 1820–1827. 27 indexed citations
10.
Passaro, Maureen, et al.. (2001). [Use of GnRH analogues in the treatment of virilizing tumors].. PubMed. 53(1 Suppl 1). 139–45. 2 indexed citations
11.
Lacroix, Agnès, Jane A. Cauley, Rod Jackson, et al.. (2000). Does statin use reduce risk of fracture in postmenopausal women? Results from the womens health initiative observational study. 1. 155. 1 indexed citations
12.
Levetan, Claresa, Maureen Passaro, K. A. Jablonski, & Robert E. Ratner. (1999). Effect of physician specialty on outcomes in diabetic ketoacidosis.. Diabetes Care. 22(11). 1790–1795. 83 indexed citations
13.
Colacurci, Nicola, et al.. (1998). Effects of hormone replacement therapy on glucose metabolism.. PubMed. 40(1). 18–21. 22 indexed citations
14.
Levetan, Claresa, Maureen Passaro, Kathleen Jablonski, Mary E. Kass, & Robert E. Ratner. (1998). Unrecognized Diabetes Among Hospitalized Patients. Diabetes Care. 21(2). 246–249. 242 indexed citations
15.
Colacurci, Nicola, et al.. (1998). Bone density in women with endometriosis.. PubMed. 40(2). 126–7. 1 indexed citations
16.
Cizza, Giovanni, Lynnette K. Nieman, John L. Doppman, et al.. (1996). Factitious Cushing syndrome.. The Journal of Clinical Endocrinology & Metabolism. 81(10). 3573–3577. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026